Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001

Journal of the National Cancer Institute

Volumn 100, Issue 14, 2008, Pages 1003-1012

  Kinsey, Tracy ^a   Jemal, Ahmedin ^b   Liff, Jonathan ^a   Ward, Elizabeth ^b   Thun, Michael ^b  

^a EMORY UNIVERSITY   (United States)

^b AMERICAN CANCER SOCIETY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST CANCER; CANCER MORTALITY; COLON CANCER; EDUCATIONAL STATUS; FEMALE; GROWTH; HUMAN; LOGLINEAR MODEL; LUNG CANCER; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; STATISTICAL SIGNIFICANCE; UNITED STATES;

ADULT; AFRICAN AMERICANS; BREAST NEOPLASMS; COLORECTAL NEOPLASMS; CONFOUNDING FACTORS (EPIDEMIOLOGY); EDUCATIONAL STATUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; LINEAR MODELS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PROSTATIC NEOPLASMS; RESEARCH DESIGN; SEX DISTRIBUTION; UNITED STATES;

EID: 47649129248     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djn207     Document Type: Article

References (78)

1. Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov). SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969-2004), Bethesda, MD: National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch. Released April 2007. Underlying mortality data provided by NCHS. www.cdc.gov/nchs. Accessed April 1, 2008.
2. Edwards BK, Howe HL, Ries LA, et al. Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer. 2002;94(10):2766-2792.
3. Thun MJ, Jemal A. How much of the decrease in cancer death rates in the United States is attributable to reductions in tobacco smoking? Tob Control. 2006;15(5):345-347.
4. Wingo PA, Ries LA, Giovino GA, et al. Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst. 1999;91(8):675-690.
5. Health, United States, 2006,. With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics; 2006.
6. Jemal A, Clegg LX, Ward E, et al. Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer. 2004;101(1):3-27.
7. Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97(19):1407-1427.
8. Chu KC, Miller BA, Springfield SA. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc. 2007;99(10):1092-1100.
9. Singh GK, Miller BA, Hankey BF. Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: part II - lung and colorectal cancers. J Natl Cancer Inst. 2002;94(12):916-925.
10. Singh GK, Miller BA, Hankey BF, Feuer EJ, Pickle LW. Changing area socioeconomic patterns in U.S. cancer mortality, 1950-1998: part I - all cancers among men. J Natl Cancer Inst. 2002;94(12):904-915.
11. Steenland K, Henley J, Thun M. All-cause and cause-specific death rates by educational status for two million people in two American Cancer Society cohorts, 1959-1996. Am J Epidemiol. 2002;156(1):11-21.
12. Steenland K, Hu S, Walker J. All-cause and cause-specific mortality by socioeconomic status among employed persons in 27 US states, 1984-1997. Am J Public Health. 2004;94(6):1037-1042.
13. Albano JD, Ward E, Jemal A, et al. Cancer mortality in the United States by education level and race. J Natl Cancer Inst. 2007;99(18):1384-1394.
14. World Health Organization. International Statistical Classification of Disease and Related Health Problems: 9th Revision. Geneva, Switzerland: World Health Organization; 1977.
15. World Health Organization. International Statistical Classification of Disease and Related Health Problems: 10th Revision. Geneva, Switzerland: World Health Organization; 1992.
16. Sorlie PD, Johnson NJ. Validity of education information on the death certificate. Epidemiology. 1996;7(4):437-439.
17. Shai D, Rosenwaike I. Errors in reporting education on the death certificate: some findings for older male decedents from New York State and Utah. Am J Epidemiol. 1989;130(1):188-192.
18. Berkman LF, Macintyre S. The measurement of social class in health studies: old measures and new formulations. IARC Sci Publ. 1997;(138):51-64.
19. Rosenberg HM, Maurer JD, Sorlie PD, et al. Quality of death rates by race and Hispanic origin: a summary of current research 1999. Vital Health Stat 2. 1999;128:1-13.
20. Sorlie PD, Backlund E, Keller JB. US mortality by economic, demographic, and social characteristics: the National Longitudinal Mortality Study. Am J Public Health. 1995;85(7):949-956.
21. Howe HL, Wu X, Ries LAG, et al. Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer. 2006;107(8):1711-1742.
22. Ward E, Jemal A, Cokkinides V, et al. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54(2):78-93.
23. Anderson RN, Rosenberg HM. Age standardization of death rates: implementation of the year 2000 standard. Natl Vital Stat Rep. 1998;47(3):1-16.
24. US Department of Health and Human Services. Technical Appendix from Vital Statistics of the United States: 1999 Mortality. Hyattsville, MD: Public Health Service, Centers for Disease Control and Prevention, National Center for Health Statistics; 2004.
25. Chiang C. Standard error of the age-adjusted death rate. Vital Statistics-Special Reports. Washington, DC: Vital Statistics-Special Reports. Washington, DC: National Center for Health Statistics, Public Health Service; 1961.
26. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for join-point regression with applications to cancer rates [erratum in Stat Med. 2001;20(4):655]. Stat Med. 2000;19(3):335-351.
27. Fay MP, Tiwari RC, Feuer EJ, Zou Z. Estimating average annual percent change for disease rates without assuming constant change. Biometrics. 2006;62(3):847-854.
28. Singer J, White J. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. New York, NY: Oxford University Press, Inc; 2003.
29. Jemal A, Chu KC, Tarone RE. Recent trends in lung cancer mortality in the United States. J Natl Cancer Inst. 2001;93(4):277-283.
30. Mannino DM, Ford E, Giovino GA, Thun M. Lung cancer mortality rates in birth cohorts in the United States from 1960 to 1994. Lung Cancer. 2001;31(2-3):91-99.
31. U.S. Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2004.
32. Giovino GA. Epidemiology of tobacco use in the United States. Oncogene. 2002;21(48):7326-7340.
33. Kanjilal S, Gregg EW, Cheng YJ, et al. Socioeconomic status and trends in disparities in 4 major risk factors for cardiovascular disease among US adults, 1971-2002. Arch Intern Med. 2006;166(21):2348-2355.
34. Gilpin EA, Pierce JP. Demographic differences in patterns in the incidence of smoking cessation: United States 1950-1990. Ann Epidemiol. 2002;12(3):141-150.
35. Giovino GA, Henningfield JE, Tomar SL, Escobedo LG, Slade J. Epidemiology of tobacco use and dependence. Epidemiol Rev. 1995;17(1):48-65.
36. Nadel MR, Blackman DK, Shapiro JA, Seeff LC. Are people being screened for colorectal cancer as recommended? Results from the National Health Interview Survey. Prev Med. 2002;35(3):199-206.
37. Shapiro JA, Seeff LC, Nadel MR. Colorectal cancer-screening tests and associated health behaviors. Am J Prev Med. 2001;21(2):132-137.
38. Seeff LC, Nadel MR, Klabunde CN, et al. Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer. 2004;100(10):2093-2103.
39. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult-blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343(22):1603-1607.
40. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study [erratum in N Engl J Med. 1993;329(9):672]. N Engl J Med. 1993;328(19):1365-1371.
41. Anderson LM, May DS. Has the use of cervical, breast, and colorectal cancer screening increased in the United States? Am J Public Health. 1995;85(6):840-842.
42. Hoffman-Goetz L, Breen NL, Meissner H. The impact of social class on the use of cancer screening within three racial/ethnic groups in the United States. Ethn Dis. 1998;8(1):43-51.
43. Mandelblatt J, Andrews H, Kao R, Wallace R, Kerner J. The late-stage diagnosis of colorectal cancer: demographic and socioeconomic factors. Am J Public Health. 1996;86(12):1794-1797.
44. Swan J, Breen N, Coates RJ, Rimer BK, Lee NC. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97(6):1528-1540.
45. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264(11):1444-1450.
46. Potosky AL, Harlan LC, Kaplan RS, Johnson KA, Lynch CF. Age, sex, and racial differences in the use of standard adjuvant therapy for colorectal cancer. J Clin Oncol. 2002;20(5):1192-1202.
47. Schrag D, Cramer LD, Bach PB, Begg CB. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst. 2001;93(11):850-857.
48. Schrag D, Gelfand SE, Bach PB, Guillem J, Minsky BD, Begg CB. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results - Medicare. J Clin Oncol. 2001;19(17):3712-3718.
49. Baldwin L-M, Dobie SA, Billingsley K, et al. Explaining black-white differences in receipt of recommended colon cancer treatment. J Natl Cancer Inst. 2005;97(16):1211-1220.
50. Hodgson DC, Fuchs CS, Ayanian JZ. Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer. J Natl Cancer Inst. 2001;93(7):501-515.
51. Jessup JM, Stewart A, Greene FL, Minsky BD. Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. JAMA. 2005;294(21):2703-2711.
52. Giovannucci E, Wu K. Cancers of the colon and rectum. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention. 3rd ed. New York, NY: Oxford University Press; 2006:809-829.
53. Zhang Q, Wang Y. Trends in the association between obesity and socioeconomic status in U.S. adults: 1971 to 2000. Obes Res. 2004;12(10):1622-1632.
54. Berry DA, Cronin KA, Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353(17):1784-1792.
55. Tangka FKL, Dalaker J, Chattopadhyay SK, et al. Meeting the mammography screening needs of underserved women: the performance of the National Breast and Cervical Cancer Early Detection Program in 2002-2003 (United States). Cancer Causes Control. 2006;17(9):1145-1154.
56. Ayanian JZ, Guadagnoli E. Variations in breast cancer treatment by patient and provider characteristics. Breast Cancer Res Treat. 1996;40(1):65-74.
57. Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490-496.
58. Breen N, Kessler LG, Brown ML. Breast cancer control among the underserved - an overview. Breast Cancer Res Treat. 1996;40(1):105-115.
59. Breen N, Wesley MN, Merrill RM, Johnson K. The relationship of socioeconomic status and access to minimum expected therapy among female breast cancer patients in the National Cancer Institute Black-White Cancer Survival Study. Ethn Dis. 1999;9(1):111-125.
60. McGinnis LS, Menck HR, Eyre HJ, et al. National Cancer Data Base survey of breast cancer management for patients from low income zip codes. Cancer. 2000;88(4):933-945.
61. Wagener DK, Schatzkin A. Temporal trends in the socioeconomic gradient for breast cancer mortality among US women. Am J Public Health. 1994;84(6):1003-1006.
62. Gronberg H. Prostate cancer epidemiology. Lancet. 2003;361(9360):859-864.
63. Hsing AW, Devesa SS. Trends and patterns of prostate cancer: what do they suggest? Epidemiol Rev. 2001;23(1):3-13.
64. Etzioni R, Tsodikov A, Mariotto A, et al. Quantifying the role of PSA screening in the US prostate cancer mortality decline. Cancer Causes Control. 2008;19(2):175-181.
65. Oliver SE, May MT, Gunnell D. International trends in prostate-cancer mortality in the "PSA ERA". Int J Cancer. 2001;92(6):893-898.
66. Meng MV, Grossfeld GD, Sadetsky N, Mehta SS, Lubeck DP, Carroll PR. Contemporary patterns of androgen deprivation therapy use for newly diagnosed prostate cancer. Urology. 2002;60(3)(suppl 1):7-11; discussion 11-12.
67. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst. 2001;93(9):705-709.
68. Finney Rutten LJ, Meissner HI, Breen N, Vernon SW, Rimer BK. Factors associated with men ' s use of prostate-specific antigen screening: evidence from Health Information National Trends Survey. Prev Med. 2005;40(4):461-468.
69. Steenland K, Rodriguez C, Mondul A, Calle EE, Thun M. Prostate cancer incidence and survival in relation to education (United States). Cancer Causes Control. 2004;15(9):939-945.
70. Wolf MS, Knight SJ, Lyons EA, et al. Literacy, race, and PSA level among low-income men newly diagnosed with prostate cancer. Urology. 2006;68(1):89-93.
71. Fowke JH, Schlundt D, Signorello LB, Ukoli FAM, Blot WJ. Prostate cancer screening between low-income African-American and Caucasian men. Urol Oncol. 2005;23(5):333-340.
72. Gilligan T. Social disparities and prostate cancer: mapping the gaps in our knowledge. Cancer Causes Control. 2005;16(1):45-53.
73. Polednak AP. Prostate cancer treatment in black and white men: the need to consider both stage at diagnosis and socioeconomic status. J Natl Med Assoc. 1998;90(2):101-104.
74. Desch CE, Penberthy L, Newschaffer CJ, et al. Factors that determine the treatment for local and regional prostate cancer. Med Care. 1996;34(2):152-162.
75. Krieger N, Williams D, Moss N. Measuring social class in US public health research: concepts, methodologies, and guidelines. Ann Rev Public Health. 1997;18:341-378.
76. Hayward MD, Gorman BK. The long arm of childhood: the influence of early-life social conditions on men's mortality. Demography. 2004;41(1):87-107.
77. Winkleby M, Cubbin C. Influence of individual and neighbourhood socioeconomic status on mortality among black, Mexican-American, and white women and men in the United States. J Epidemiol Commun Health. 2003;57(6):444-452.
78. Anderson RN, Minino AM, Hoyert DL, Rosenberg HM. Comparability of cause of death between ICD-9 and ICD-10: preliminary estimates. Natl Vital Stat Rep. 2001;49(2):1-32.